Skip to content

Ramdevbaba Solvent Ltd. (RBS)

SME Cap

Consumer stocks · SME cap · NSE

Ramdevbaba Solvent Ltd. operates in Edible Oils, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹77.5
-1.50 · -1.90%
Market cap ₹192 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm IST
Details
Quote19 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result01 Jun, 07:57 pm IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags04 Oct 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Consumer P/E 22.2 (n=441)
Technical timing lens

Trend score and candlestick chart

26Bearish

full bear SMA stack · SMA20 -9.2% / mo · MACD − · sector -3.7pp vs Nifty 500 (3M)

Stock trend: 19
Sector RS: 36
Sector 3M: -9.3% vs Nifty 500 -5.6%
Consumer FPI tailwindNot confirmed

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

RBSD candles · FIT view-26.5%
Latest close ₹77.50 on 2026-10-19
Bar
-3.7%
RSI
37
MACD hist
-0.30
52W pos
28%
Visible chart range
Candle interval
2026-10-19O ₹80.50H ₹81.95L ₹77.50C ₹77.50Vol 13,600 sh
₹70.18₹80.19₹90.20₹100.21₹110.22₹77.50VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

RBSNifty Consumer DurablesNifty 500
-14%+1%+17%+32%20 Jul28 Aug19 Oct19 Oct 2026RBS +4.7%Nifty Consumer Durabl… -9.7%Nifty 500 -5.6%
RBS
+4.7%
Nifty 500
-5.6%
Nifty Consumer Durables
-9.7%
Vs Nifty 500
+10.3 pp
Chart stats
19 Oct 2026
From 52W high
-41.3%
₹132
52W range position
26%
₹58.8 - ₹132
ATR (14)
4.5%
₹3.5
Volume vs 20D
1.57x
Latest completed session
Avg traded value
₹0.1 Cr
20-session average
20D price channel
₹75 - ₹89.8
40.2% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.

Suggested next step
Verify management risk first
Do not let cheap valuation override weak Trust or governance evidence.
U-Score
Legacy · OVERVALUED
27

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Bad
0

Revenue +11.7% · PAT -37.5% YoY

Technical
Bearish
26

Price trend and sector-relative-strength timing.

Valuation
Legacy model
+61.2%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
47

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 31 Mar 2026

Bad · 0/100

PAT -38% YoY · margin compression · Rev +12% YoY · +13% QoQ

Filed 31 Mar 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹438 Cr+11.7%+13.5%
EBITDA₹12 CrNDF-14.3%
Operating margin2.7%NDF-90 bps
PAT₹5 Cr-37.5%-16.7%
PAT margin1.1%NDF-41 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
16.80
P/B
1.12
EV/EBITDA
17.77
Market Cap
192.00Cr

Profitability

ROE
7.27%
ROCE
5.39%
ROA
1.84%
Dividend Y
—

Growth (CAGR)

Revenue 5Y
15.00%
EPS 5Y
13.00%
Revenue 3Y
6.00%
EPS 3Y
-8.00%

Balance Sheet

Debt/Equity
2.20
Interest Coverage
2.60×
Altman Z
2.21
Book Value
71.30

Cash Flow

FCF Yield
—
FCF Positive Y
0/5
OCF
-56.00 Cr
EPS TTM
5.00

Shareholding

Promoter Hold
64.39%
Promoter Pledge
0.00%
Momentum 52W
32%

Financial History

Updated 19/10/2026

Revenue

₹ Cr
Latest: 438+13.5% vs prev
0527.0Mar 2023: 346Sep 2023: 295Mar 2024: 392Sep 2024: 402Mar 2025: 527Sep 2025: 386Mar 2026: 438FY23Q2 23FY24Q2 24FY25Q2 25FY26

Net Profit

₹ Cr
Latest: 5.0-16.7% vs prev
08.0Mar 2023: 8.0Sep 2023: 6.0Mar 2024: 8.0Sep 2024: 8.0Mar 2025: 7.0Sep 2025: 6.0Mar 2026: 5.0FY23Q2 23FY24Q2 24FY25Q2 25FY26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Bearish setup

Trend is weak — long-term trend down. RSI 37.

  • Price < SMA20 < SMA50 < SMA200 — full bearish stack.
  • SMA20 falling (~10.1% over last month) — short-term momentum negative.
  • RSI(14) at 37 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 38% off 52W high · 32% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

35
RS percentile
Stage 1 Base / Transition
1M return
-10.9%
3M return
+0.0%
6M return
+2.6%
1Y return
-37.0%
RS 1D
+4
RS 20D
+2
Sector rank
#9
Industry rank
#46
Stage evidence
  • Price is 10.4% below the 30-week proxy without full trend alignment.
  • The 30-week proxy changed -0.6% over 20 sessions.
  • The moving-average structure does not confirm Stage 2 or Stage 4.
50-DMA
price below
200-DMA
price below
Sector
neutral
Industry
neutral
Relative-strength line vs Nifty 500 (base 100)
250 observations
19 Oct 2026Value 65.49-0.88%
51647892105Sept 25Feb 26Jun 26Oct 2665
RS vs Nifty 50065

Valuation & peers

U-Score 27 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

27U-SCORE
OVERVALUED

Fundamental score breakdown

U band · OVERVALUED
Valuation18/30
Growth11/25
Quality0/20
Balance Sheet5/15
Cash Flow0/10
Piotroski
3/9 (+1)
Penalties
-8
Raw sum
27

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

27/100 · legacy band OVERVALUED

Positive drivers

  • Fair-value margin of safety is positive at 61.2%.
  • Valuation contributes 18/30 to the score.
  • Growth contributes 11/25 to the score.

Main drags

  • Penalty bucket subtracts 8 points.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Cash flow is weaker at 0/10; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
16.8
PB
1.1
EV/EBITDA
17.8
ROE
7.3%
ROCE
5.4%
FCF Yield
—
Debt/Equity
2.2
MoS
+61.2%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE. Debt/equity is 2.2, so downturn resilience matters.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
27
Previous: 27
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
+61.2%
Previous: +61.2%

Score history

12 stored score snapshots. Latest stored move: +0 points.

20 Oct 2026
v4.3-runtime-valuation
27
27
27
27
27
27
27
27
27
27
27
27

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹89.56
+13.5% MoS
Growth-justified P/E
40.0
Growth-justified Value
₹199.8
+61.2% MoS
PEG
1.29

Comparable companies

Peers

Business-comparable peers in Consumer — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
MKPL
Small
M K Proteins Limited
FMCG
match 159
14
31.2
9.4%
-617%
OVERVALUED
KRITINUT
Small
Kriti Nutrients Limited
FMCG
match 151
66
10.4
15.1%
+67%
UNDERVALUED
MODINATUR
Small
Modi Naturals Limited
FMCG
match 146
74
8.9
30.2%
+72%
UNDERVALUED
KNAGRI
Small
KN Agri Resources Limited
FMCG
match 145
35
13.9
8.9%
-13%
WATCHLIST
SUNDROP
Small
Sundrop Brands Limited
FMCG
match 144
24
101.0
1.3%
-1944%
OVERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

Ramdevbaba Solvent Ltd. operates in Edible Oils, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
47Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 4th percentile of the scored universe and 5th percentile within Consumer. Main check: cash conversion is weak at 28/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
0 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
4th percentile

overall median 67 · Consumer: 5th pctile, median 66 · SME: 4th pctile, median 64

Evidence depth
Financial-only

0 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
90
strong · holding, pledge, alignment
Cash flow
28
weak · profit to cash conversion
Balance sheet
40
weak · leverage and solvency
Discipline
30
weak · capital discipline
Results
56
watch · quarterly consistency

Trust positives

  • ▸Promoter holding is 64.4%.
  • ▸Promoter pledge is zero.
  • ▸Promoter holding increased 5.2%.
  • ▸OPM spread across recent quarters is 1.8%.

Trust risks

  • ▸Operating cash flow is negative at ₹-56 Cr.
  • ▸Debt/equity is 2.20.
  • ▸Only 0 years of positive FCF.
  • ▸ROCE is low at 5.4%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

5 shown
Annual reportSep 2026

Sep 2026 · General Updates 25 Aug - Ramdevbaba Solvent filed FY2025-26 annual report; AGM on September 23, 2026.

Source: Nse

Open source ↗
Annual reportSep 2026

Sep 2026 · Outcome of Board Meeting 21 Aug - Board approved annual report, AGM on 23 September 2026, book closure dates, and cost audit report.

Source: Nse

Open source ↗
Annual reportAug 2026

Aug 2026 · Trading Window 12 Aug - Board meeting on 21 Aug 2026 to approve annual report, AGM notice, and record dates; trading window closes.

Source: Nse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.